Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2006; 48:1289-1298, doi:10.1016/j.jacc.2006.05.062 (Published online 11 September 2006).
© 2006 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Donahue, M. P.
Right arrow Articles by Rockman, H. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Donahue, M. P.
Right arrow Articles by Rockman, H. A.

Redefining Heart Failure

The Utility of Genomics

Mark P. Donahue, MD, MHS*,{dagger},*, Douglas A. Marchuk, PhD{ddagger} and Howard A. Rockman, MD*,{ddagger}

* Division of Cardiovascular Medicine
{dagger} Duke Clinical Research Institute
{ddagger} Department of Molecular Genetics and Microbiology, Durham, North Carolina


Figure 1
View larger version (16K):

[in a new window]
 
Figure 1 Integrating genomic evidence into the management of cardiomyopathy. Genomics can potentially assist at many points of our current care model. This figure illustrates the potential points of integration of genomic information into current standard of care. EP = electrophysiology.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement